NFKB1 and psoriasis: A scoping review on the effects of GLP-1-RAs in inflammatory arthritis and psoriasis revealed that these agents have anti-inflammatory properties through inhibition of the NF-κB pathway; however, how these effects translate clinically is limited to case reports, small uncontrolled prospective cohorts, and two small RCTs in psoriasis with conflicting results [17].